Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-15-001816
Filing Date
2015-03-16
Accepted
2015-03-16 17:25:18
Documents
1
Period of Report
2015-02-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4021815steinhart_actinum.html 4  
1 OWNERSHIP DOCUMENT f4021815steinhart_actinum.xml 4 3942
  Complete submission text file 0001213900-15-001816.txt   5384
Mailing Address 125 ELM STREET NEW CANAAN CT 06840
Business Address
Steinhart Richard I (Reporting) CIK: 0001293789 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 15704111

Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations